Monodonal antibodies
(MAb) to a 36 KD protein, proliferating cell nudear antigen (PCNA/cyclin), have been previously shown to be capable of identifying proliferating cells in vitro as well as in alcohol-fixed, paraffin-embedded ussue specimens.
The routine use of these anti-PCNA/cydin MAb in investigative studies and in diagnostic pathology requires a dearer understanding ofthe distribution of PCNA/ cydlin in the different cell populations found in tissue specimens.
We therefore compared the ability of MAb to three nudeus-associated proliferation markers (MAb 
Introduction
Cell kinetic information is becoming increasingly important as a potential prognostic indicator in cancer treatment and as a method for evaluating response to radiotherapy and chemotherapy regimens (1, 5, 10, 23, 24, 28) . In addition, the study ofproliferating cells in nontransformed disease processes (e.g. , atherosclerotic plaques) is an important part of defining the cellular mechanisms in these diseases (29 mm. Slides were washed three times, in PBS between labeling steps. Fluorescent controls were included which lacked the first or second primary antibodies and/or fluorescent secondary antibodies. No significant crosslabeling or nonspecific labeling was seen using this order of antibody placement.
A minimum of400 cells was counted for each cell type/double labeling combination, using an inverted iinmunofluorescence microscope (Leitz). A cell was considered positive when the staining intensity was high enough to identify the characteristic nuclear patterns for the different antibodies (see Results). Figure 4b ).
Results

ImmunoJluorescence
Ki-67/BU-1 Double Labeling
In the HeLa, A431, and HUVE cell lines, BU-1-positive cells formed an inclusive subset of the Ki-67 positive cells ( Figures  4c and 4d ).
The SK-5 cell line also had overlap ofthe Ki-67-positive and BU-1positive populations but included a very rare single BU-1-positive/Ki-67-negative cell.
Anti-PCNA/BU-1 Double Labeling
For the HeLa and A431 cell lines, the BU-1-positive cells formed an inclusive subset of the PCNA/cyclin positive cells ( Figure  4e ). The HeLa BU-1-positive cells tended to be among the most intensely stained for PCNA/cyclin. This same relationship was noted in the A431 cells to a lesser degree.
For the HUVE cell line, the staining patterns overlapped incompletely, with rare BU-1-positive/PCNA-negative cells.
Finally, the SK-5 cell line manifested no overlap of the PCNApositive and BU-1-positive populations when the cells were fixed immediately after BrdU incubation ( Figure  4f ). An additional elapsed-time experiment was then performed as described in 
Discussion
In the present study we tested the hypothesis that, among differ- as HeLa, which appear to have high levels of PCNA/cyclin (4,25). with antibody 19A2. Note variegated, fine granular pattern confined to majority of cell nuclei. Bar = 10 tm.
___________________________________________________________
Figure2.
BrdUlocalization in HUVE cellsas identified by indirect immunofluo- Figure 3 . Antibody Ki-67 immunolocalization in HUVE cells using avidin-biorescence with antibody BU-1 . Note coarse, granular pattern confined to minority tin immunofluorescence method (see text for details). Note two different stainof cell nuclei. Bar = 10 m.
ing patterns: clumped (arrow) and unclumped (arrowhead). Bar = 10 tm. (11, 12) . Therefore, using these two "signposts," expression of PCNA/cyclin in different phases of the cell cycle was compared in different cell lines.
As would be expected from Figure  5, 
